“…Beyond medication, patients and clinicians propose a variety of supports from pharmaceuticals, society, family, and patient’s personal pharmacogenomics for managing hypertension. Social isolation, low income, depression, or psychological distress have been ascertained as causes of withdrawal during treatment [3,16,18,19]. Statistical analyses from the investigation of African American women, Latino migrants, seasonal farmworkers, Chinese people, and people from south-west Nigeria have illustrated that social supports could promote patient adherence to treatment via sharing information and assisting in bringing about life style changes [20,21,22,23].…”